Wound care technology developer Next Science has launched a range of topical collagen products to complement its’ BlastX anti-microbial wound gel infection treatments. Collagen is the most important protein in the human body, and is critical for the reconstruction of a stable skin barrier and wound closure. Topical collagen can have a positive effect on…
By Peter Roberts Microbial resistance to antibiotics and sanitising agents is on everyone’s mind in recent times, with resistant strains already in the news even before Covid-19 hit. But two Australian companies, Wintermute Biomedical and Next Science, have been quietly developing genuinely new chemistries that represent potential breakthroughs in halting infections. Next Science’s XPerience No…
Wound care technology developer Next Science will begin commercial sales immediately of its XPerience No Rinse Antimicrobial Solution after it received US Food and Drug Administration approval to market the product. The company’s shares soared 14.5 per cent yesterday on the news to $1.62, with the Sydney company claiming a US$15 billion market potential. Next…
Wound care technology developer Next Science was hit by shutdowns of elective surgeries and wound care clinics in the United States during the first six months of 2020, curbing revenue. Sales for the six months were $1.9 million, a small reduction on the previous corresponding period. Sales of Bactisure wound wash, BlastX anti-microbial wound gel…
Biotechnology start-up Next Science plans to launch five new products in 2020 as the company records increasing sales with its first anti-bacterial products. The company recorded $633,000 in sales in the first quarter of the calendar year, largely of its Bactisure wound wash, BlastX anti-microbial wound gel and its just launched acne creams and gels.…
Biotechnology start-up Next Science (ASX: NXS) recorded strong sales growth in 2018 as acceptance grew of its novel technologies to kill bacteria. The Sydney company reported sales of $6.1 million for the year of its Xbio technology products which attack the biofilm that surrounds and protects bacteria. Four of its products have secured US FDA…
Biotechnology start-up Next Science (ASX: NXS) has emerged as one of the top five performing stocks on the ASX with investors recognising a promising new platform technoogy. The company, which raised $35 million to develop its technology to kill bacteria, rose 35 per cent on listing in April, as reported in @AuManufacturing news. Now its…
The Cooperative Research Centres Association will host its Collaborate Innovate 2021 Conference at Parliament House, Canberra next week, examining collaborative innovation and the impact of “covid, climate change, digital transformation and geo-economic volatility.”
Professor Thas Nirmalathas, Interim Dean since January 2024, will officially begin as Dean of the Faculty of Engineering and Information Technology at the University of Melbourne on Monday. Nirmalathas (pictured) is a professor on electrical and electronic engineering as well as a Fellow of both Engineers Australia and the Australian Academy of Technological Sciences and…
The Department of Defence has released an Innovation, Science and Technology (IS&T) strategy, aimed at leveraging Australia’s scientific capability in defence. Accelerating Asymmetric Advantage – Delivering More, Together is Defence’s 10-year vision for the Defence IS&T ecosystem. Chief Defence Scientist Professor Tanya Monro said: “This vision integrates and aligns the Defence IS&T ecosystem to meet…
